• 1
    Keck PE Jr, McElroy SL, Arnold LM. Bipolar disorder. Med. Clin. North Am. 2001; 85: 645661.
  • 2
    Keck PE Jr, McElroy SL, Strakowski SM et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am. J. Psychiatry 1998; 155: 646652.
  • 3
    Goodwin FK, Jamison KR, Ghaemi SN. Manic–Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd edn. Oxford University Press, New York, 2007; 128131.
  • 4
    American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry 2002; 159: 150.
  • 5
    Goodwin GM. Evidence-based guidelines for treating bipolar disorder: Revised second edition-recommendations from the British Association for Psychopharmacology. J. Psychopharmacol 2009; 23: 346388.
  • 6
    National Collaborating Centre for Mental Health. Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. The British Psychological Society & The Royal College of Psychiatrists, Leicester, UK, 2006.
  • 7
    Yatham LN, Kennedy SH, Schaffer A et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2009. Bipolar Disord. 2009; 11: 225255.
  • 8
    Muzina DJ, Calabrese JR. Maintenance therapies in bipolar disorder: Focus on randomized controlled trials. Aust. N. Z. J. Psychiatry 2005; 39: 652661.
  • 9
    Fawcett J. Valproate use in acute mania and bipolar disorder: An international perspective. J. Clin. Psychiatry 1989; 50 (Suppl.): 1012.
  • 10
    Blanco C, Laje G, Olfson M, Marcus SC, Pincus HA. Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am. J. Psychiatry 2002; 159: 10051010.
  • 11
    Kim JH, Cha BS, Ha KS. Trends in pharmacotherapy of the hospitalized patients with bipolar disorder: A twelve-year naturalistic study. Korean J. Psychopharmacol. 2002; 13: 3746.
  • 12
    Suppes T, Dennehy EB, Hirschfeld RM et al. The Texas implementation of medication algorithms: Update to the algorithms for treatment of bipolar I disorder. J. Clin. Psychiatry 2005; 66: 870886.
  • 13
    Macritchie KA, Geddes JR, Scott J, Haslam DR, Goodwin GM. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst. Rev. 2001; 3: CD003196.
  • 14
    Findling RL, McNamara NK, Youngstrom EA et al. Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry 2005; 44: 409417.
  • 15
    Calabrese JR, Shelton MD, Rapport DJ et al. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am. J. Psychiatry 2005; 162: 21522161.
  • 16
    Geddes JR, Goodwin GM, Rendell J et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial. Lancet 2010; 375: 385395.
  • 17
    Bowden CL, Calabrese JR, McElroy SL et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch. Gen. Psychiatry 2000; 57: 481489.
  • 18
    Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): The CGI-BP. Psychiatry Res. 1997; 73: 159171.
  • 19
    Lambert PA, Venaud G. Comparative study of valpromide versus lithium in treatment of affective disorders. Nervure: Journal de Psychiatrie 1992; 5: 5765 (in French).
  • 20
    Altman S, Haeri S, Cohen LJ et al. Predictors of relapse in bipolar disorder: A review. J. Psychiatr. Pract. 2006; 12: 269282.
  • 21
    Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC. Antipsychotic dose equivalents and dose-years: A standardized method for comparing exposure to different drugs. Biol. Psychiatry 2010; 67: 255262.
  • 22
    Shin YC, Min KJ, Yoon BH et al. Korean medication algorithm for bipolar disorder: Second revision. Asia Pac. Psychiatry 2013; 5: 301308.
  • 23
    Cipriani A, Barbui C, Salanti G et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: A multiple-treatments meta-analysis. Lancet 2011; 378: 13061315.
  • 24
    Smith LA, Cornelius V, Warnock A, Bell A, Young AH. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: A systematic review of randomized controlled trials. Bipolar Disord. 2007; 9: 394412.